UV Flu Technologies, Inc.
UVFT
$0.00
$0.00100.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -19.58% | 93.33% | 226.77% | -50.00% | 10.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.58% | 93.33% | 226.77% | -50.00% | 10.76% |
| Cost of Revenue | -45.77% | 49.40% | 638.36% | 19.38% | -17.20% |
| Gross Profit | 60.49% | 207.29% | 68.01% | -84.92% | 3,340.00% |
| SG&A Expenses | -15.89% | -54.68% | -3.63% | -49.18% | 15.33% |
| Depreciation & Amortization | 11.11% | -59.18% | -73.17% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.54% | -48.26% | 11.61% | -43.82% | 5.26% |
| Operating Income | 25.77% | 61.53% | 12.43% | 42.30% | -2.56% |
| Income Before Tax | 21.43% | 48.84% | -14.22% | 41.26% | -11.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.43% | 48.84% | -14.22% | 41.26% | -11.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.43% | 48.84% | -14.22% | 41.26% | -11.87% |
| EBIT | 25.77% | 61.53% | 12.43% | 42.30% | -2.56% |
| EBITDA | 26.20% | 61.56% | 12.53% | 43.29% | -1.20% |
| EPS Basic | 50.00% | 62.22% | 0.00% | 51.22% | 5.26% |
| Normalized Basic EPS | 54.55% | 60.71% | -4.76% | 48.00% | 8.33% |
| EPS Diluted | 50.00% | 62.22% | 0.00% | 51.22% | 5.26% |
| Normalized Diluted EPS | 54.55% | 60.71% | -4.76% | 48.00% | 8.33% |
| Average Basic Shares Outstanding | 60.09% | 36.66% | 12.45% | 19.70% | 19.78% |
| Average Diluted Shares Outstanding | 60.09% | 36.66% | 12.45% | 19.70% | 19.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |